Structures by: Kennedy A. R.
Total: 953
Ethyl 4-nitro-1-(4-pentynyl)-1<i>H</i>-pyrrole-2-carboxylate
C12H14N2O4
Acta Crystallographica Section E (2017) 73, 2 254-259
a=7.8839(4)Å b=16.1443(7)Å c=10.2058(5)Å
α=90.00° β=104.472(5)° γ=90.00°
<i>N</i>-[3-(Dimethylamino)propyl]-1-isopentyl-4-nitro-1<i>H</i>-pyrrole-2-carboxamide
C15H26N4O3
Acta Crystallographica Section E (2017) 73, 2 254-259
a=17.5744(7)Å b=11.3718(6)Å c=8.7299(4)Å
α=90.00° β=92.076(4)° γ=90.00°
1-(3-Azidopropyl)-4-(1-methyl-4-nitro-1<i>H</i>-pyrrole-2-carboxamido)-<i>N</i>-[2-(morpholin-4-yl)ethyl]-1<i>H</i>-pyrrole-2-carboxamide
C20H27N9O5
Acta Crystallographica Section E (2017) 73, 2 254-259
a=11.2809(4)Å b=16.4528(6)Å c=12.5130(5)Å
α=90.00° β=106.542(4)° γ=90.00°
<i>L</i>-Asparaginium chloride monohydrate
C4H9N2O3,Cl,H2O
Acta Crystallographica Section E (2018) 74, 11 1619-1623
a=5.09220(10)Å b=10.1450(2)Å c=8.1950(2)Å
α=90° β=103.834(2)° γ=90°
<i>L</i>-Asparaginium bromide monohydrate
C4H9N2O3,Br,H2O
Acta Crystallographica Section E (2018) 74, 11 1619-1623
a=5.2167(2)Å b=10.2784(5)Å c=8.3063(4)Å
α=90° β=103.606(5)° γ=90°
<i>L</i>-Asparaginium iodide monohydrate
C4H9N2O3,I,H2O
Acta Crystallographica Section E (2018) 74, 11 1619-1623
a=5.3668(5)Å b=10.6744(8)Å c=8.4532(6)Å
α=90° β=102.772(8)° γ=90°
Bis[μ-(1,3-dimesityl-1<i>H</i>-imidazol-3-ium-2-yl)methanolato-κ^2^<i>O</i>:<i>O</i>]bis[dichloridocopper(II)]
C44H52Cl4Cu2N4O2
Acta Crystallographica Section E (2018) 74, 9 1369-1372
a=11.1962(8)Å b=13.5321(10)Å c=15.5615(8)Å
α=90° β=107.705(6)° γ=90°
Hibiscus acid dimethyl sulfoxide monosolvate
C6H6O7,C2H6OS
Acta Crystallographica Section E (2017) 73, 9 1368-1371
a=5.4258(2)Å b=8.9491(3)Å c=11.4365(3)Å
α=90° β=94.092(3)° γ=90°
Hibiscus acid dimethyl ester
C8H10O7
Acta Crystallographica Section E (2017) 73, 9 1368-1371
a=9.3057(6)Å b=7.6934(6)Å c=13.4012(11)Å
α=90° β=96.243(7)° γ=90°
N-(2-hidroxy-5-methylphenyl)benzamide
C14H13NO2
Acta Crystallographica Section E (2015) 71, 12 o943
a=7.2263(3)Å b=21.7442(7)Å c=7.4747(3)Å
α=90° β=110.280(5)° γ=90°
<i>N</i>,<i>N</i>-Dimethyl-2-[(4-methylbenzyl)sulfonyl]ethanamine
C12H19NO2S
Acta Crystallographica Section E (2015) 71, 7 757-759
a=5.3642(3)Å b=10.3773(6)Å c=12.1784(7)Å
α=99.572(5)° β=95.498(5)° γ=104.645(5)°
2-Methyl-3-nitrobenzoic anhydride
C16H12N2O7
Acta Crystallographica Section E (2015) 71, 7 o451
a=10.6332(5)Å b=11.6961(4)Å c=12.7934(6)Å
α=90° β=111.930(6)° γ=90°
3-chloro-N-(2-nitrophenyl)benzamide
C13H9ClN2O3
Acta Crystallographica Section E (2015) 71, 9 o674
a=12.6300(9)Å b=14.1462(12)Å c=6.7797(6)Å
α=90° β=105.475(7)° γ=90°
12-(2-Hydroxy-6-oxocyclohex-1-enyl)-9,10-dihydro-8<i>H</i>-benzo[<i>a</i>]xanthen-11(12<i>H</i>)-one
C23H20O4
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 10 o1558-9
a=14.2855(15)Å b=13.7461(12)Å c=18.400(2)Å
α=90° β=90° γ=90°
1-{(<i>E</i>)-[(2-Fluoro-5-nitrophenyl)imino]methyl}naphthalen-2-ol
C17H11FN2O3
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 6 o850-1
a=14.2226(6)Å b=13.0856(5)Å c=7.3801(3)Å
α=90° β=94.151(4)° γ=90°
14-Bromo-12-chloro-2,16-dioxapentacyclo[7.7.5.0^1,21^.0^3,8^.0^10,15^]henicosa-3(8),10,12,14-tetraene-7,20-dione
C19H16BrClO4
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 5 o769-70
a=10.2741(6)Å b=10.2800(6)Å c=15.8581(8)Å
α=90° β=102.073(5)° γ=90°
3-Amino-1-phenyl-1<i>H</i>-benzo[<i>f</i>]chromene-2-carbonitrile
C20H14N2O
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 3 o401
a=9.4059(8)Å b=6.5009(5)Å c=12.4919(10)Å
α=90° β=105.914(9)° γ=90°
2-{[(4-Azaniumylphenyl)sulfonyl]azanidyl}pyrimidinium chloride monohydrate
C10H11N4O2S,Cl,H2O
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 900-907
a=5.4118(4)Å b=11.5632(8)Å c=11.7430(8)Å
α=109.462(7)° β=94.399(6)° γ=102.509(7)°
2-{[(4-azaniumylphenyl)sulfonyl]azanidyl}pyrimidin-1-ium chloride methanol hemisolvate
C10H11N4O2S,Cl,0.5(CH4O)
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 900-907
a=5.6468(2)Å b=11.2749(4)Å c=11.8363(8)Å
α=64.254(5)° β=79.361(6)° γ=77.687(6)°
2-{[(4-Azaniumylphenyl)sulfonyl]azanidyl}pyrimidin-1-ium bromide monohydrate
C10H11N4O2S,Br,H2O
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 900-907
a=11.9420(3)Å b=5.6295(2)Å c=21.0659(6)Å
α=90.00° β=98.380(3)° γ=90.00°
Bis(2-{[(4-azaniumylphenyl)sulfonyl]azanidyl}pyrimidin-1-ium) tetraiodide
2(C10H11N4O2S),I42
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 900-907
a=5.7792(4)Å b=12.0002(7)Å c=12.5214(9)Å
α=61.964(7)° β=87.745(5)° γ=76.426(5)°
2-{[(4-Azaniumylphenyl)sulfonyl]azanidyl}pyrimidin-1-ium tetrafluoroborate monohydrate
C10H11N4O2S,BF4,H2O
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 900-907
a=5.85390(10)Å b=11.3629(3)Å c=21.2080(6)Å
α=90.00° β=90.982(2)° γ=90.00°
2-{[(4-Azaniumylphenyl)sulfonyl]azanidyl}pyrimidin-1-ium nitrate
C10H11N4O2S,NO3
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 900-907
a=5.4705(4)Å b=10.1235(7)Å c=11.9956(8)Å
α=86.708(6)° β=85.489(6)° γ=74.394(7)°
4-[(Pyrimidin-2-yl)sulfamoyl]anilinium 4-hydroxybenzenesulfonate dihydrate
C10H11N4O2S,C6H5O4S,2(H2O)
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 900-907
a=18.5872(5)Å b=5.9733(2)Å c=18.6850(5)Å
α=90.00° β=104.858(3)° γ=90.00°
4-[(Pyrimidin-2-yl)sulfamoyl]anilinium ethanesulfonate
C10H11N4O2S,C2H5O3S
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 900-907
a=5.5269(4)Å b=34.979(3)Å c=8.4395(6)Å
α=90.00° β=93.102(7)° γ=90.00°
3,4-dichloronitrobenzene--aniline (2/1)
2C6H3Cl2NO2,C6H7N
Acta Crystallographica Section E (2005) 61, 7 o2318-o2319
a=6.9774(2)Å b=10.1668(3)Å c=27.6762(7)Å
α=90.00° β=96.495(2)° γ=90.00°
Dichlorobis(triphenylphosphine oxide-κO)nickel(II)
C36H30Cl2NiO2P2
Acta Crystallographica Section E (2004) 60, 12 m1861-m1862
a=20.6356(3)Å b=32.5388(6)Å c=9.72400(10)Å
α=90.00° β=90.00° γ=90.00°
2-(1-Piperidinyl)-1,3-benzothiazole
C12H14N2S
Acta Crystallographica Section E (2005) 61, 3 o569-o570
a=15.3509(6)Å b=11.6315(4)Å c=5.9802(2)Å
α=90.00° β=90.00° γ=90.00°
Carbamazepine N,N-dimethylformamide solvate
C15H12N2O,C3H7N1O
Acta Crystallographica Section E (2005) 61, 5 o1509-o1511
a=7.7118(4)Å b=9.1503(4)Å c=11.6969(6)Å
α=100.192(3)° β=95.379(2)° γ=101.908(3)°
Hydrochlorothiazide N,N-dimethylformamide solvate
C7H8ClN3O4S2,C3H7NO
Acta Crystallographica Section E (2006) 62, 5 o1730-o1732
a=7.3028(2)Å b=9.1492(2)Å c=23.6989(6)Å
α=86.1940(10)° β=89.8410(10)° γ=72.8550(10)°
<i>m</i>-Nitrophenylmaleimide
C10H6N2O4
Acta Crystallographica Section E (2006) 62, 7 o2734-o2735
a=18.9815(6)Å b=6.6643(2)Å c=14.8702(4)Å
α=90.00° β=90.00° γ=90.00°
Hydrochlorothiazide N,N-dimethylacetamide solvate (1/2)
C7H8ClN3O4S2,2C4H9NO
Acta Crystallographica Section E (2006) 62, 7 o2926-o2928
a=17.0841(6)Å b=7.3905(3)Å c=17.7937(7)Å
α=90.00° β=106.875(2)° γ=90.00°
C11H13NO
C11H13NO
Acta Crystallographica Section E (2002) 58, 6 o642-o643
a=7.7769(4)Å b=6.2492(3)Å c=9.6263(5)Å
α=90.00° β=92.749(2)° γ=90.00°
NH4O1,C6H6NO41
NH4O1,C6H6NO41
Acta Crystallographica Section E (2003) 59, 9 o1410-o1412
a=4.6788(2)Å b=13.3277(6)Å c=13.5380(7)Å
α=90.00° β=97.212(2)° γ=90.00°
Hydrochlrothiazide DMSO solvate
C7H8ClN3O4S2,C2H6OS
Acta Crystallographica Section E (2006) 62, 6 o2288-o2290
a=7.5068(4)Å b=9.8272(5)Å c=10.7311(6)Å
α=85.639(3)° β=73.896(3)° γ=80.246(3)°
4-Aminopyridinium isonicotinate monohydrate
C5H7N2,C6H4NO2,H2O
Acta Crystallographica Section E (2005) 61, 2 o333-o334
a=6.7128(3)Å b=6.7911(2)Å c=13.6379(8)Å
α=75.830(3)° β=75.999(2)° γ=78.326(3)°
(η^6^-N,N-Diethylaniline)(η^4^-1,2,3,4-tetramethylcyclobutadiene)cobalt(I) hexafluorophosphate
C18H27CoN,F6P1
Acta Crystallographica Section E (2005) 61, 2 m302-m303
a=8.4201(2)Å b=16.2404(3)Å c=15.1960(4)Å
α=90.00° β=103.8440(10)° γ=90.00°
4-Chlorobenzoic acid N,N-dimethylformamide solvate
C7H5ClO2,C3H7NO
Acta Crystallographica Section E (2004) 60, 11 o1950-o1951
a=6.1269(2)Å b=14.6159(5)Å c=12.6541(4)Å
α=90.00° β=103.228(2)° γ=90.00°
C7H4N2O6,C6H7NO
C7H4N2O6,C6H7NO
Acta Crystallographica Section E (2002) 58, 1 o50-o52
a=9.2223(2)Å b=6.32660(10)Å c=23.4991(4)Å
α=90.00° β=93.6067(7)° γ=90.00°
Methyl 2-amino-5-isopropyl-1,3-thiazole-4-carboxylate
C8H12N2O2S
Acta Crystallographica Section E (2004) 60, 9 o1510-o1512
a=8.4219(13)Å b=9.9620(12)Å c=12.4307(15)Å
α=90° β=90.916(11)° γ=90°
Carbamazepine furfural hemisolvate
C15H12N2O,0.5C5H4O2
Acta Crystallographica Section E (2005) 61, 6 o1777-o1779
a=5.1815(4)Å b=26.0450(19)Å c=20.5735(15)Å
α=90.00° β=91.302(2)° γ=90.00°
(C6H3Cl2NO2)4.(C4H8N2)'
C6H3Cl2N1O2,0.25C4H8N2
Acta Crystallographica Section E (2005) 61, 11 o3666-o3667
a=7.3850(3)Å b=9.7359(3)Å c=13.7218(5)Å
α=69.347(2)° β=87.209(2)° γ=67.945(2)°
Hexaaqua(4-chloro-3-formylbenzenesulfonato)calcium(II) 4-chloro-3-formylbenzenesulfonate monohydrate
[Ca(C7H4Cl1O4S1)(H2O)6](C7H4Cl1O4S1),H2O
Acta Crystallographica Section E (2006) 62, 2 m339-m341
a=6.4750(2)Å b=24.7258(7)Å c=7.3573(2)Å
α=90° β=93.2126(2)° γ=90°
3-Nitro-1-(triisopropylsilyl)-1H-pyrrole
C13H24N2O2Si
Acta Crystallographica Section E (2006) 62, 8 o3282-o3284
a=9.6924(5)Å b=15.9437(10)Å c=10.1267(6)Å
α=90.00° β=95.089(4)° γ=90.00°
Ethyl 2-aminooxazole-5-carboxylate
C6H8N2O3
Acta Crystallographica Section E (2001) 57, 9 o832-o833
a=6.1295(6)Å b=7.8227(6)Å c=8.3961(8)Å
α=113.592(7)° β=93.831(4)° γ=95.557(4)°
N,N'-bis(salicylidene)-1,4,butanediamine
C18H20N2O2
Acta Crystallographica Section E (2001) 57, 11 o1027-o1028
a=8.7330(2)Å b=5.8710(3)Å c=15.3070(6)Å
α=90.0° β=90.5350(10)° γ=90.0°
Catena-Poly[benzyltrimethylammonium [cadmium(II)-tri-μ~2~-thiocyanato]]
C10H16N,C3CdN3S3
Acta Crystallographica Section E (2006) 62, 7 m1630-m1632
a=9.9668(3)Å b=10.8210(3)Å c=16.5299(5)Å
α=90.00° β=102.351(2)° γ=90.00°
Hydrochlorothiazide aniline solvate
C7H8ClN3O4S2,C6H7N
Acta Crystallographica Section E (2005) 61, 8 o2520-o2522
a=9.7757(3)Å b=10.5004(3)Å c=15.6093(4)Å
α=90.00° β=91.692(2)° γ=90.00°
Hydrochlorothiazide--1,4-dioxane (1/1)
C7H8ClN3O4S2,C4H8O2
Acta Crystallographica Section E (2005) 61, 8 o2573-o2575
a=6.6684(2)Å b=9.8585(3)Å c=12.9149(4)Å
α=87.046(2)° β=78.017(2)° γ=70.872(2)°
C9H14N2O2S
C9H14N2O2S
Acta Crystallographica Section E (2004) 60, 7 o1188-o1190
a=7.8757(10)Å b=9.1080(11)Å c=15.8434(12)Å
α=90.00° β=100.853(9)° γ=90.00°
C10H6N2O4
C10H6N2O4
Acta Crystallographica Section E (2003) 59, 11 o1717-o1718
a=10.535(2)Å b=11.624(3)Å c=8.148(2)Å
α=90.00° β=109.69(3)° γ=90.00°
Ethyl 2-({6-amino-2-(benzylsulfanyl)-5-[2-(ethoxycarbonyl)prop-2-enyl]pyrimidin- 4-yloxy}methyl)acrylate
C23H27N3O5S
Acta Crystallographica Section E (2006) 62, 1 o324-o326
a=7.3668(2)Å b=11.5842(3)Å c=14.5700(4)Å
α=111.692(2)° β=99.520(2)° γ=93.076(2)°
[MgBr~2~(C~6~H~15~N)(C~4~H~10~O)]
[MgBr~2~(C~6~H~15~N)(C~4~H~10~O)]
Acta Crystallographica Section C (1998) 54, 9 1238-1240
a=13.9138(16)Å b=8.2036(13)Å c=14.555(2)Å
α=90.00° β=99.836(10)° γ=90.00°
Trans-bromo-ortho-tolyl-bis(triphenylphosphine)palladium(II)
C43H37BrP2Pd
Acta Crystallographica Section C (1995) 51, 2 208-210
a=11.061(1)Å b=12.171(1)Å c=14.334(2)Å
α=95.200(8)° β=92.094(9)° γ=105.191(8)°
Trans-bromo-ortho-tolyl-bis(triphenylphosphine)palladium(II)
C43H37BrP2Pd
Acta Crystallographica Section C (1995) 51, 2 208-210
a=11.0691(4)Å b=12.1779(11)Å c=14.3380(7)Å
α=95.161(6)° β=92.072(4)° γ=105.199(6)°
C38H34Cl3O6P2Rh
C38H34Cl3O6P2Rh
Acta Crystallographica Section C (1993) 49, 6 1146-1148
a=12.158(2)Å b=12.689(2)Å c=13.8220(10)Å
α=86.670(10)° β=65.150(10)° γ=78.650(10)°
C36H66N2NiO8P2
C36H66N2NiO8P2
Acta Crystallographica Section C (1997) 53, 3 292-293
a=9.573(4)Å b=20.857(6)Å c=20.467(7)Å
α=90° β=95.86(3)° γ=90°
C16H21AlClN
C16H21AlClN
Acta Crystallographica Section C (1998) 54, 3 335-337
a=9.720(2)Å b=9.735(2)Å c=10.111(2)Å
α=93.12(2)° β=112.80(2)° γ=108.05(2)°
C4H3N3O4
C4H3N3O4
Acta Crystallographica Section C (1998) 54, 4 547-550
a=5.8730(10)Å b=9.6930(10)Å c=10.4561(9)Å
α=90° β=104.070(10)° γ=90°
C4H3N3O4,C2H6O1S1
C4H3N3O4,C2H6O1S1
Acta Crystallographica Section C (1998) 54, 4 547-550
a=8.8580(10)Å b=6.9619(6)Å c=15.8220(10)Å
α=90° β=95.823(8)° γ=90°
C13H17NO
C13H17NO
Acta Crystallographica Section C (1998) 54, 7 978-980
a=8.4830(10)Å b=19.174(3)Å c=7.1793(8)Å
α=90° β=90° γ=90°
2,8-Dimethylphenoxathiin-10-oxide
C14H12O2S
Acta Crystallographica Section C (1998) 54, 10 1511-1513
a=13.274(2)Å b=12.214(4)Å c=15.044(3)Å
α=90.00° β=110.606(14)° γ=90.00°
C12H14N2O4
C12H14N2O4
Acta Crystallographica Section C (1997) 53, 6 744-746
a=12.231(2)Å b=13.643(3)Å c=7.733(3)Å
α=90° β=90° γ=90°
C19H24O5
C19H24O5
Acta Crystallographica Section C (1997) 53, 6 746-748
a=7.3900(10)Å b=12.490(2)Å c=19.223(3)Å
α=90° β=91.750(10)° γ=90°
C6H13Ca2NO11
C6H13Ca2NO11
Acta Crystallographica Section C (1999) 55, 3 324-326
a=17.882(5)Å b=6.8049(9)Å c=11.712(6)Å
α=90.00° β=90.00° γ=90.00°
C10H11NO3
C10H11NO3
Acta Crystallographica Section C (1999) 55, 2 234-236
a=7.2264(9)Å b=8.0250(18)Å c=16.5902(12)Å
α=90° β=92.052(8)° γ=90°
C5H10N2O3S
C5H10N2O3S
Acta Crystallographica Section C (1999) 55, 2 232-234
a=9.088(2)Å b=8.108(2)Å c=10.505(2)Å
α=90° β=102.140(10)° γ=90°
C12H24N6O6S3
C12H24N6O6S3
Acta Crystallographica Section C (1999) 55, 2 232-234
a=14.5300(10)Å b=8.0567(8)Å c=15.928(2)Å
α=90° β=101.642(8)° γ=90°
C7H10N2O3S
C7H10N2O3S
Acta Crystallographica Section C (1999) 55, 7 IUC9900072
a=7.5544(17)Å b=8.5939(12)Å c=14.489(2)Å
α=77.136(11)° β=86.800(15)° γ=88.879(16)°
C12H32Br2Li2N4
C12H32Br2Li2N4
Acta Crystallographica Section C (1999) 55, 8 IUC9900078
a=11.904(4)Å b=12.042(2)Å c=15.436(4)Å
α=90° β=112.48(2)° γ=90°
Cholest-5-enyl-3β,4β-diacetate
C31H50O4
Acta Crystallographica Section C (1999) 55, 9 1570-1572
a=6.293(3)Å b=10.255(2)Å c=22.172(5)Å
α=90.00° β=96.17(3)° γ=90.00°
Hydrochlorothiazide N-methyl-2-pyrrolidone disolvate
C7H8ClN3O4S2,2C5H9NO
Acta Crystallographica Section E (2006) 62, 11 o5169-o5171
a=17.0756(6)Å b=7.4819(3)Å c=17.9978(6)Å
α=90.00° β=105.211(2)° γ=90.00°
Chlorothiazide--pyridine (1/3)
C7H6ClN3O4S2,3(C5H5N)
Acta Crystallographica Section E (2008) 64, 6 o1105-o1106
a=9.0697(15)Å b=11.863(2)Å c=11.875(2)Å
α=100.691(7)° β=98.667(8)° γ=98.134(7)°
Dihydrocarbamazepine formamide
C15H14N2O,CH3NO
Acta Crystallographica Section E (2007) 63, 9 o3888-o3889
a=8.4690(4)Å b=9.0215(4)Å c=10.3137(4)Å
α=74.363(3)° β=83.630(3)° γ=70.847(3)°
4-picoline N-oxide--hydroquinone (1/1)
C6H7NO,C6H6O2
Acta Crystallographica Section E (2007) 63, 4 o1534-o1536
a=13.0486(2)Å b=11.2091(2)Å c=9.0905(3)Å
α=90.00° β=121.625(2)° γ=90.00°
10,11-Dihydrocarbamazepine--formic acid (1/1)
C15H14N2O,CH2O2
Acta Crystallographica Section E (2007) 63, 3 o1469-o1470
a=5.2298(4)Å b=9.3849(12)Å c=14.4858(18)Å
α=83.853(5)° β=88.230(7)° γ=88.221(7)°
Chlorothiazide formic acid solvate (1/2)
C7H6ClN3O4S2,2(CH2O2)
Acta Crystallographica Section E (2007) 63, 10 o4021-o4021
a=8.2985(5)Å b=21.5271(14)Å c=8.3676(5)Å
α=90.00° β=105.580(3)° γ=90.00°
10,11-Dihydrocarbamazepine--acetic acid (1/1)
C15H14N2O,C2H4O2
Acta Crystallographica Section E (2006) 62, 12 o5361-o5362
a=5.3104(4)Å b=15.4246(17)Å c=18.732(2)Å
α=90.00° β=95.106(7)° γ=90.00°
Chlorothiazide DMSO solvate
C7H6ClN3O4S2,C2H6OS
Acta Crystallographica Section E (2007) 63, 5 o2423-o2423
a=9.0965(3)Å b=11.2081(4)Å c=15.8916(5)Å
α=109.009(2)° β=103.384(2)° γ=96.246(2)°
Chlorothiazide N,N-dimethylacetamide solvate
C7H6ClN3O4S2,2C4H9NO
Acta Crystallographica Section E (2007) 63, 5 o2422-o2422
a=8.2037(3)Å b=24.5226(6)Å c=10.6443(3)Å
α=90.00° β=105.231(2)° γ=90.00°
Cytenamide--formic acid (1/1)
C16H13NO,CH2O2
Acta Crystallographica Section E (2008) 64, 8 o1379-o1380
a=11.5351(13)Å b=13.9095(15)Å c=17.6904(19)Å
α=90.00° β=95.846(5)° γ=90.00°
C36H44Cl2N2O2Zr,0.5C7H8
C36H44Cl2N2O2Zr,0.5C7H8
Acta Crystallographica Section C (2001) 57, 6 674-675
a=29.2399(4)Å b=12.5188(2)Å c=23.8447(4)Å
α=90.00° β=119.6495(6)° γ=90.00°
Bis-μ-methanol-κ^4^<i>O</i>:<i>O</i>-bis{[hydrotris(3-phenyl-2-sulfanylidene-2,3-dihydro-1<i>H</i>-1,3-imidazol-1-yl)borato-κ^3^<i>H</i>,<i>S</i>,<i>S</i>](methanol-κ<i>O</i>)sodium(I)}
C58H60B2N12Na2O4S6
Acta Crystallographica Section C (2014) 70, 5 421-427
a=12.6969(5)Å b=19.4915(6)Å c=13.2609(4)Å
α=90.00° β=113.777(4)° γ=90.00°
Bis-μ-methanol-κ^4^<i>O</i>:<i>O</i>-bis{[hydrotris(3-isopropyl-2-sulfanylidene-2,3-dihydro-1<i>H</i>-1,3-imidazol-1-yl)borato-κ^3^<i>H</i>,<i>S</i>,<i>S</i>](methanol-κ<i>O</i>)sodium(I)}—–diethyl ether—–methanol (1/0.3333/0.0833)
(C40H72B2N12Na2O4S6),0.3333(C4H10O1),0.0833(C1H4O1)
Acta Crystallographica Section C (2014) 70, 5 421-427
a=53.903(2)Å b=14.4391(4)Å c=22.9832(4)Å
α=90.00° β=96.256(3)° γ=90.00°
Poly[[μ-hydrotris(3-methyl-2-sulfanylidene-2,3-dihydro-1<i>H</i>-1,3-imidazol-1-yl)borato]sodium(I)]
C12H16BN6NaS3
Acta Crystallographica Section C (2014) 70, 5 421-427
a=7.9707(3)Å b=10.0754(4)Å c=11.4672(5)Å
α=79.923(4)° β=82.774(4)° γ=71.167(4)°
C43H37BrP2Pd
C43H37BrP2Pd
Acta Crystallographica Section C (1995) 51, 208-210
a=11.0610(10)Å b=12.1710(10)Å c=14.334(2)Å
α=95.200(8)° β=92.094(9)° γ=105.191(8)°
C43H37BrP2Pd
C43H37BrP2Pd
Acta Crystallographica Section C (1995) 51, 208-210
a=11.0691(4)Å b=12.1779(11)Å c=14.3380(7)Å
α=95.161(6)° β=92.072(4)° γ=105.199(6)°
<i>catena</i>-poly[[diaquacalcium(II)]-bis(μ-1-naphthoato)- κ^3^<i>O</i>,<i>O</i>:<i>O</i>;κ^3^<i>O</i>:<i>O</i>,<i>O</i>']
C22H18CaO6
Acta Crystallographica Section C (2012) 68, 8 m213-m218
a=21.0790(10)Å b=11.4410(6)Å c=7.7200(3)Å
α=90.00° β=93.994(3)° γ=90.00°
<i>catena</i>-poly[[[diaquabis(1-naphthoato-κ<i>O</i>)magnesium(II)]-μ-aqua] dihydrate]
C22H20MgO7,2(H2O)
Acta Crystallographica Section C (2012) 68, 8 m213-m218
a=12.8896(4)Å b=8.0048(2)Å c=24.5300(5)Å
α=90.00° β=121.1900(10)° γ=90.00°
<i>catena</i>-poly[[diaquastrontium(II)]-bis(μ-1-naphthoato)- κ^3^<i>O</i>,<i>O</i>:<i>O</i>;κ^3^<i>O</i>:<i>O</i>,<i>O</i>']
C22H18O6Sr
Acta Crystallographica Section C (2012) 68, 8 m213-m218
a=21.2740(19)Å b=11.3397(10)Å c=7.9619(5)Å
α=90.00° β=94.520(4)° γ=90.00°
<i>catena</i>-poly[[diaquabarium(II)]-bis(μ-1-naphthoato)- κ^3^<i>O</i>,<i>O</i>:<i>O</i>;κ^3^<i>O</i>:<i>O</i>,<i>O</i>']
C22H18BaO6
Acta Crystallographica Section C (2012) 68, 8 m213-m218
a=20.464(3)Å b=11.9699(15)Å c=8.2812(10)Å
α=90.00° β=90.00° γ=90.00°
C10H10O5
C10H10O5
Acta Crystallographica Section C (2000) 56, 6 e265-e266
a=10.4676(18)Å b=10.4774(15)Å c=10.5727(18)Å
α=71.878(12)° β=64.619(12)° γ=69.533(12)°
C16H36N,C3H12B9BrH12MnO3
C16H36N,C3H12B9BrH12MnO3
Acta Crystallographica Section C (2001) 57, 3 269-270
a=11.74690(10)Å b=18.2581(2)Å c=14.55580(10)Å
α=90.00° β=101.3520(10)° γ=90.00°
C12H12N42,C6Cl2O42,2CH2Cl2
C12H12N42,C6Cl2O42,2CH2Cl2
Acta Crystallographica Section C (2003) 59, 11 o613-o615
a=7.6066(9)Å b=8.7846(9)Å c=9.3316(11)Å
α=99.918(4)° β=95.556(4)° γ=101.534(5)°
C16H17N3O4S,1.9H2O
C16H17N3O4S,1.9H2O
Acta Crystallographica Section C (2003) 59, 11 o650-o652
a=31.548(2)Å b=11.8574(9)Å c=15.6654(11)Å
α=90.00° β=112.364(2)° γ=90.00°
Bis[N,N'-bis(2-isopropylphenyl)pentane-2,4-diiminato]magnesium(II)
C46H58MgN4
Acta Crystallographica Section C (2003) 59, 12 m549-m551
a=16.6252(10)Å b=10.6287(5)Å c=23.831(2)Å
α=90.00° β=95.484(5)° γ=90.00°
Catena-poly[bromotetrakis(μ2-tert-butoxo)- bis(tetrahydrofuran-?O)iron(III)dilithium]
C24H52BrFeLi2O6
Acta Crystallographica Section C (2005) 61, 7 m346-m347
a=18.4449(5)Å b=9.0987(3)Å c=18.6750(5)Å
α=90.00° β=90.535(2)° γ=90.00°
4'-fluoroacetoacetanilide
C10H10FNO2
Acta Crystallographica Section C (2002) 58, 11 o645-o648
a=4.98110(10)Å b=20.7383(4)Å c=18.4869(5)Å
α=90° β=93.0210(10)° γ=90°
2'-fluoroacetoacetanilide
C10H10FNO2
Acta Crystallographica Section C (2002) 58, 11 o645-o648
a=7.3215(2)Å b=12.0480(3)Å c=10.5082(3)Å
α=90° β=98.8770(10)° γ=90°
Bis[μ-P,P-methylenebis(diisopropyl phosphonate)-κ^3^O,O':O]bis[chlorolithium(I)]
C26H60Cl2Li2O12P4
Acta Crystallographica Section C (2003) 59, 2 m49-m51
a=10.2172(2)Å b=10.3740(3)Å c=10.8197(3)Å
α=84.2355(12)° β=68.9131(12)° γ=76.9692(10)°